Eloxx Pharmaceuticals Reports Third Quarter 2019 Financial and Operating Results and Provides Business Update

    NEXT STORY
    Aptose Reports Results for the Third Quarter Ended September 30, 2019
    PREV STORY
    G1 Therapeutics Provides Third Quarter 2019 Corporate and Financial Update
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Invitation to the Special and Extraordinary Shareholders’ Meetings of 26 July 2016 – Nomination of Mary Kerr for Galapagos’ Board of Directors

    MECHELEN, Belgium, June 23, 2016 (GLOBE NEWSWIRE) -- Galapagos NV (Euronext & NASDAQ: GLPG) ...

    author_avatar
    NASDAQ Market News

    ZH Healthcare announces blueEHR collaboration with Sanford Health to enable global healthcare

    MCLEAN, Va., Sept. 18, 2017 (GLOBE NEWSWIRE) -- ZH Healthcare announced that blueEHR, the company’s customizable eHealth ...

    author_avatar
    NASDAQ Market News

    Immunocore presents Phase 2 tebentafusp clinical results at ESMO Immuno-Oncology Virtual Congress 2020

    author_avatar
    NASDAQ Market News